 Astellas Pharma Inc. OTCPK:ALPMF Q3 2022 Earnings Conference Call October 31, 2022 4:00 AM ET Company Representatives Kenji Yasukawa - Chief Executive Officer Yoshitsugu Shitaka - CScO, Chief Scientific Officer Minoru Kikuoka - Chief Financial Officer Tadaaki Taniguchi - Chief Medical Officer Bernie Zeiher - Chief Medical Officer Hiromitsu Ikeda - Corporate Head, Advocacy and Relations Conference Call Participants Hidemaru Yamaguchi - Citigroup Securities Motoya Koutani - Nomura Securities Fumiyoshi Sakai - Credit Suisse Shinichiro Muraoka - Morgan Stanley MUFG Securities Kazuaki Hashiguchi - Daiwa Securities Akinori Ueda - Goldman Sachs Securities Seiji Wakao - JPMorgan Stephen Barker - Jefferies Securities Operator Thank you very much for your participation in this is the FY 2022 Second Quarter Financial Results Earnings Call. Im Ikeda from Corporate Advocacy Relationship serving as the moderator for today. 